Literature DB >> 14724229

Semaphorin3D guides retinal axons along the dorsoventral axis of the tectum.

Yan Liu1, Jason Berndt, Fengyun Su, Hiroshi Tawarayama, Wataru Shoji, John Y Kuwada, Mary C Halloran.   

Abstract

We examined the role of Sema3D, a semaphorin of previously unknown function, in guiding retinal ganglion cell (RGC) axons to the optic tectum in the developing zebrafish. Sema3D is expressed more strongly in the ventral versus dorsal tectum, suggesting that it may participate in guiding RGC axons along the dorsoventral axis of the tectum. Ubiquitous misexpression of Sema3D in transgenic zebrafish inhibits ventral but not dorsal RGC axon growth. In addition, ventral RGC axons avoid or stop at individual cells misexpressing Sema3D along their pathway. Sema3D ubiquitous misexpression at later stages also causes ventral RGC axon arbors to spread more widely along the dorsoventral axis of the tectum. Knock-down of Sema3D with morpholino antisense causes ventral RGC axons to extend aberrantly into the ventral tectum. These results suggest that Sema3D in the ventral tectum normally acts to inhibit ventral RGCs from extending into ventral tectum, ensuring their correct innervation of dorsal tectum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724229      PMCID: PMC6730002          DOI: 10.1523/JNEUROSCI.4287-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

1.  nev (cyfip2) is required for retinal lamination and axon guidance in the zebrafish retinotectal system.

Authors:  Andrew J Pittman; John A Gaynes; Chi-Bin Chien
Journal:  Dev Biol       Date:  2010-06-09       Impact factor: 3.582

2.  The calmodulin-stimulated adenylate cyclase ADCY8 sets the sensitivity of zebrafish retinal axons to midline repellents and is required for normal midline crossing.

Authors:  Hong Xu; Sarah G Leinwand; Alison L Dell; Emma Fried-Cassorla; Jonathan A Raper
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.

Authors:  Kelly A McClellan; Vladimir A Ruzhynsky; David N Douda; Jacqueline L Vanderluit; Kerry L Ferguson; Danian Chen; Rod Bremner; David S Park; Gustavo Leone; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

4.  Expression patterns of Ephs and ephrins throughout retinotectal development in Xenopus laevis.

Authors:  Valerie Higenell; Sang Myung Han; David A Feldheim; Frank Scalia; Edward S Ruthazer
Journal:  Dev Neurobiol       Date:  2012-04       Impact factor: 3.964

5.  cAMP-induced expression of neuropilin1 promotes retinal axon crossing in the zebrafish optic chiasm.

Authors:  Alison L Dell; Emma Fried-Cassorla; Hong Xu; Jonathan A Raper
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

Review 6.  Visual map development: bidirectional signaling, bifunctional guidance molecules, and competition.

Authors:  David A Feldheim; Dennis D M O'Leary
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-29       Impact factor: 10.005

Review 7.  Semaphorins and their Signaling Mechanisms.

Authors:  Laura Taylor Alto; Jonathan R Terman
Journal:  Methods Mol Biol       Date:  2017

8.  Proteoglycan-mediated axon degeneration corrects pretarget topographic sorting errors.

Authors:  Fabienne E Poulain; Chi-Bin Chien
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

9.  Sema4C expression in neural stem/progenitor cells and in adult neurogenesis induced by cerebral ischemia.

Authors:  Haitao Wu; Jundie Fan; Lingling Zhu; Shuhong Liu; Yan Wu; Tong Zhao; Yanrui Wu; Xuefeng Ding; Wenhong Fan; Ming Fan
Journal:  J Mol Neurosci       Date:  2009-02-03       Impact factor: 3.444

10.  Multiple EphB receptors mediate dorsal-ventral retinotopic mapping via similar bi-functional responses to ephrin-B1.

Authors:  Todd McLaughlin; Yoo-Shick Lim; Alicia Santiago; Dennis D M O'Leary
Journal:  Mol Cell Neurosci       Date:  2014-07-19       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.